New Alzheimer’s Drug Slows Aging

By Crowdability, on Friday, November 20, 2015

You rely on Crowdability to bring you the best deals. Now, rely on us to share the most up-to-date news, trends and opinion. You won’t find this stuff in the mainstream press. Look for it every Friday morning.

Scientist Opts for a $94,000 Brain Implant

Every now and then, a scientist comes along who is so dedicated to their work that they decide to experiment on themselves. Phil Kennedy is one of those scientists.

Hacker group declares: “We'll wipe ISIS off the Internet”

ISIS is the Islamic militant group behind the recent deadly attacks in Paris. One of its most valuable tools for planning such attacks is the Internet. Now, “Anonymous,” a group of Internet users who hack and spread leaked information, is aiming to force ISIS into Internet obscurity. Prepare for massive cyber attacks.

[Video]: A Five-Story Vending Machine for Cars 

After buying a car online, customers of Carvana get a customized, oversized coin. Wait until you see what happens when they drop that coin into an oversized slot. Is it magic?

Spy Firm Releases Price List for Online Attack Techniques

A broker of spy technologies just published a price chart for different classes of digital intrusion techniques. It buys these secret techniques from hackers, and resells them to customers that include government agencies. Price check on Aisle 3?

New Alzheimer’s Drug Slows Aging

A new drug candidate aimed at combating Alzheimer's disease has a surprising effect: it seems to slow the aging process. Could this be the fountain of youth?

Comments

If you enjoyed this article, subscribe to updates:

Sign-up today and you'll receive our daily insights on early-stage investing, as well as our FREE "Equity Crowdfunding Action Kit" – where you'll learn:

  • The Ins & Outs of Equity Crowdfunding
  • A step-by-step path to get started
  • Tips from dozens of Venture Capitalists
subscribe to updates

Thank you for subscribing!

Tags: Alzheimers Hacking Isis

Share This:
comments powered by Disqus